Back Sheridan, C (14 April 2025) 'Not just obesity: GLP-1 receptor agonists advance on addiction', Nature Biotechnology , 43, 455-47.Back Sims, EK, Carr, ALJ, Oram, RA, et al (15 July 2022) '100 years of insulin: celebrating the past, present and future of diabetes therapy', Nature Medicine , 27/7, 1154-64
Fewer sick days
The 1520% outcomes published in SURMOUNT-1 reflect patients who combined medication with dietary counselling and activity modification
Furthermore, hepatic insulin sensitivity was only compromised in obese individuals ( n = 20) when NAFLD was present [66]
If you take other medications, work with your healthcare provider to ensure they continue working as expected
In a range of studies, it has had a huge effect on peoples Circadian Rhythm (your sleeping pattern)